MOACM
TVRD

Mutual of America Capital Management’s Tvardi Therapeutics TVRD Stock Holding History

Mutual of America Capital Management’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-249
Closed -$84K – 1600
2022
Q3 		$84K Buy
249
+51
+26% +$18.5K ﹤0.01% 1553
2022
Q2 		$65K Buy
198
+30
+18% +$10.5K ﹤0.01% 1576
2022
Q1 		$73K Buy
168
+8
+5% +$3.28K ﹤0.01% 1578
2021
Q4 		$70K Buy
160
+4
+3% +$2.01K ﹤0.01% 1590
2021
Q3 		$87K Sell
156
-14
-8% -$7.02K ﹤0.01% 1563
2021
Q2 		$87K Buy
+170
New +$108K ﹤0.01% 1587

Other funds holding TVRD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mutual of America Capital Management's TVRD Position: Q4 2022 in Review

Mutual of America Capital Management sold out of Tvardi Therapeutics (TVRD) in Q4 2022, closing a stake of 249 shares — an estimated $84K sold.

Mutual of America Capital Management first reported a position in TVRD in Q2 2021 and held it in 6 quarters. The position peaked at $87K in Q3 2021. 160 funds tracked by Wall St. Rank hold TVRD as of Q4 2022.

  • Mutual of America Capital Management reported no remaining Tvardi Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Mutual of America Capital Management sold 249 Tvardi Therapeutics shares in Q4 2022, an estimated $84K.
  • Mutual of America Capital Management first reported a position in Tvardi Therapeutics in Q2 2021 and held it in 6 quarters.
  • Mutual of America Capital Management's Tvardi Therapeutics position peaked at $87K in Q3 2021.
  • 160 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2022.

Based on Mutual of America Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.